SUBSTRATES FOR DRUG DELIVERY DEVICE AND METHODS OF PREPARING AND USE
An assembly and method for producing a condensation aerosol are disclosed. The assembly includes a heat-conductive metal substrate with an oxidation resistant exterior surface and a drug composition film on the exterior surface and is for use in an aerosol device. The thickness of the film and the surface of the substrate is such that the aerosol formed by vaporizing and condensing the drug composition the aerosol contain 10% by weight or less drug-degradation products and at least 50% of the total amount of the drug composition in the film. The methods for treating the exterior surface include heat and chemical treatment and formation of a protective overcoat.
1 . A drug-supply assembly comprising:
a heat conductive substrate;
a non-reactive exterior surface on the heat conductive substrate; and
a film comprising a compound on the non-reactive exterior surface.
2 . The drug-supply assembly of claim 1 , wherein the heat conductive substrate is a metal.
3 . The drug-supply assembly of claim 2 , wherein the metal is selected from the group consisting of steel, stainless steel, aluminum, chromium, copper, iron, and titanium.
4 . The drug-supply assembly of claim 3 , wherein the stainless steel is selected from the group consisting of an austenitic alloy, a ferritic alloy, or a combination thereof.
5 . The drug-supply assembly of claim 2 , wherein the metal is treated to generate a non-reactive metal species on a surface of the substrate.
6 . The drug-supply assembly of claim 5 , wherein the metal is treated by heating the metal and the non-reactive metal species comprises oxidized metal.
7 . The drug-supply assembly of claim 6 , wherein the oxidized metal is selected from the group consisting of iron oxide, chromium oxide, nickel oxide, molybdenum oxide, silicon oxide and aluminum oxide.
8 . The drug-supply assembly of claim 5 , wherein the metal is treated by chemicals and the non-reactive metal species comprises oxidized metal.
9 . The drug-supply assembly of claim 8 , wherein the oxidized metal is selected from the group consisting of iron oxide, chromium oxide, and aluminum oxide.
10 . The drug-supply assembly of claim 1 , wherein the non-reactive exterior surface comprises an oxidized metal layer on the substrate.
11 . The drug-supply assembly of claim 1 , wherein the non-reactive exterior surface comprises zirconium oxide, aluminum oxide, silicon oxide, silicon carbide an inert metal, or a combination thereof.
12 . The drug-supply assembly of claim 11 , wherein the inert metal is gold and/or platinum.
13 . The drug-supply assembly of claim 1 , further comprising a heating element in thermal communication with the heat conductive substrate.
14 . The drug-supply assembly of claim 13 , wherein the heating element supplies heat to the substrate to produce a substrate temperature of at least about 250° C.
15 . The drug-supply assembly of claim 14 , wherein the substrate temperature is sufficient to volatilize the film from the non-reactive exterior surface.
16 . The drug-supply assembly of claim 1 , wherein the film comprises a drug.
17 . The drug-supply assembly of claim 1 , wherein the film is about 0.05 to 20 microns thick.
18 . The drug-supply assembly of claim 16 , wherein the film comprises a therapeutically effective amount of drug upon vaporization.
19 . A condensation aerosol device comprising the drug-supply assembly of claim 1 .